The TANGO Consortium (Post-Transplant Glomerular Diseases) is an exciting collaborative effort between patients, physicians, researchers, and industry partners looking at the recurrence of glomerular disease after transplantation
39 Transplant Centers Across 5 Continents
Health Data Collected of Over 1250 Participants
Biorepository With Patient Samples
Why This Research Is Important
Glomerular disease is a condition that affects the glomeruli, the units of the kidney that filter waste and remove extra fluids from the blood. It is the third leading cause of kidney failure in the U.S. and commonly recurs following kidney transplant surgery, shortening the life of the new kidney.
It remains unclear why glomerular disease recurs in some patients, while not in others. Many physicians tried to elucidate this challenging problem within kidney transplant research. Most of these studies were only based on few patients, making it difficult to establish evidence-based clinical guidelines.
We believe collaboration is the only way forward to effectively tackle this rare and challenging disease entity. This is why our team founded the TANGO Consortium, an international network of patients, physicians, researchers, and industry partners that collaborate to study glomerular disease recurrence after kidney transplantation.
What We Do
We obtain health information from glomerular disease patients enabling us to study disease progression and treatment response
We connect patients, scientists, physicians and industry partners with transplant centers across multiple continents to advance this research
We have a biorepository of blood and urine samples of glomerular disease patients, to identify underlying causes of disease, and determine potential novel biomarkers of recurrence
We provide an educational platform for patients with glomerular disease after transplantation
For patients Interested in participating
Any transplant patient with glomerular disease or those on the kidney transplant waitlist, based in the US